Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 26, which means every article in Cancer Science & Therapy has got 26 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
Year wise published articles |
42 | 79 | 71 | 70 | 52 |
Year wise citations received |
382 | 474 | 462 | 467 | 468 |
| Journal total citations count | 3358 |
| Journal impact factor | 2.10 |
| Journal 5 years impact factor | 5.75 |
| Journal cite score | 5.29 |
| Journal h-index | 26 |
| Journal h-index since 2016 | 18 |
A validation of carbon fiber imaging couch top modeling in two radiation therapy treatment planning systems: Philips Pinnacle3 and BrainLAB iPlan RT Dose |
|
Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches |
|
Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array |
|
The clinical impact of the couch top and rails on IMRT and arc therapy |
|
Dosimetric effects caused by couch tops and immobilization devices: Report of AAPM Task Group 176 |
|
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives |
|
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers |
|
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing |
|
BRCA gene mutations: A population based review |
|
The Role of Precision Medicine in the Diagnosis and Treatment of Patients with Rare Cancers |
|
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study |
|
Pathogenic Variants in BRIP1, RAD51C, and RAD51D Identified with Multi-Gene Panel Testing for Hereditary Cancers |
|
A new approach in cancer treatment: poly (ADP-ribose) polymerase-1 inhibitors |
|
Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies |
|
How to Screen for Hereditary Cancers in General Pathology Practice |
|
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research |
|
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review |
|
Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies |
|
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat |
|
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes |
|
Cancer Science & Therapy received 3358 citations as per Google Scholar report
